1. Home
  2. DUOT vs INKT Comparison

DUOT vs INKT Comparison

Compare DUOT & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DUOT
  • INKT
  • Stock Information
  • Founded
  • DUOT 1990
  • INKT 2017
  • Country
  • DUOT United States
  • INKT United States
  • Employees
  • DUOT N/A
  • INKT N/A
  • Industry
  • DUOT Computer Software: Prepackaged Software
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • DUOT Technology
  • INKT Health Care
  • Exchange
  • DUOT Nasdaq
  • INKT Nasdaq
  • Market Cap
  • DUOT 34.8M
  • INKT 28.5M
  • IPO Year
  • DUOT N/A
  • INKT 2021
  • Fundamental
  • Price
  • DUOT $3.76
  • INKT $0.75
  • Analyst Decision
  • DUOT Strong Buy
  • INKT Strong Buy
  • Analyst Count
  • DUOT 1
  • INKT 2
  • Target Price
  • DUOT $6.00
  • INKT $6.50
  • AVG Volume (30 Days)
  • DUOT 42.7K
  • INKT 32.0K
  • Earning Date
  • DUOT 11-19-2024
  • INKT 11-14-2024
  • Dividend Yield
  • DUOT N/A
  • INKT N/A
  • EPS Growth
  • DUOT N/A
  • INKT N/A
  • EPS
  • DUOT N/A
  • INKT N/A
  • Revenue
  • DUOT $5,638,027.00
  • INKT N/A
  • Revenue This Year
  • DUOT $66.43
  • INKT N/A
  • Revenue Next Year
  • DUOT $83.75
  • INKT N/A
  • P/E Ratio
  • DUOT N/A
  • INKT N/A
  • Revenue Growth
  • DUOT N/A
  • INKT N/A
  • 52 Week Low
  • DUOT $1.94
  • INKT $0.57
  • 52 Week High
  • DUOT $5.74
  • INKT $1.90
  • Technical
  • Relative Strength Index (RSI)
  • DUOT 42.74
  • INKT 54.46
  • Support Level
  • DUOT $4.08
  • INKT $0.74
  • Resistance Level
  • DUOT $4.94
  • INKT $0.80
  • Average True Range (ATR)
  • DUOT 0.34
  • INKT 0.05
  • MACD
  • DUOT -0.11
  • INKT 0.01
  • Stochastic Oscillator
  • DUOT 4.07
  • INKT 62.60

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Share on Social Networks: